Viatris (VTRS) Non-Current Deferred Tax Liability (2019 - 2026)

Viatris (VTRS) recorded quarterly Non-Current Deferred Tax Liability of $870.6 million in Q1 2026, down 2.4% quarter-over-quarter from $892.0 million in Q4 2025, and down 19.58% on a YoY basis from $1.1 billion in Q1 2025.

Viatris (VTRS) Non-Current Deferred Tax Liability (2019 - 2026) Analysis & Trends

Viatris' Non-Current Deferred Tax Liability history runs 8 years deep, the most recent figure standing at $870.6 million for Q1 2026.

  • In Q1 2026, Non-Current Deferred Tax Liability fell 19.58% year-over-year to $870.6 million; the TTM figure through Mar 2026 stood at $870.6 million (down 19.58% YoY), while the FY2025 annual figure was $892.0 million, down 19.49% from the prior year.
  • Non-Current Deferred Tax Liability was $870.6 million for Q1 2026 at Viatris, down from $892.0 million in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $2.8 billion in Q4 2023 to a low of $870.6 million in Q1 2026.
  • Historically, Non-Current Deferred Tax Liability has averaged $1.8 billion across 5 years, with a median of $1.7 billion in 2024.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Deferred Tax Liability advanced 14.22% in 2023, then plunged 60.12% in 2024.
  • A 5-year view of Non-Current Deferred Tax Liability shows it stood at $2.4 billion in 2022, then grew by 14.22% to $2.8 billion in 2023, then sank by 60.12% to $1.1 billion in 2024, then decreased by 19.49% to $892.0 million in 2025, then fell by 2.4% to $870.6 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $870.6 million (Q1 2026), $892.0 million (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Viatris - - 1.16 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 870.60 Mn
Mar 31, 2026 870.60 Mn
Dec 31, 2025 892.00 Mn
Dec 31, 2025 892.00 Mn
Sep 30, 2025 1.03 Bn
Sep 30, 2025 1.03 Bn
Jun 30, 2025 1.08 Bn
Jun 30, 2025 1.08 Bn
Mar 31, 2025 1.08 Bn
Mar 31, 2025 1.08 Bn
Dec 31, 2024 1.11 Bn
Dec 31, 2024 1.11 Bn
Sep 30, 2024 1.28 Bn
Sep 30, 2024 1.28 Bn
Jun 30, 2024 1.57 Bn
Jun 30, 2024 1.57 Bn
Mar 31, 2024 1.67 Bn
Mar 31, 2024 1.67 Bn
Dec 31, 2023 2.78 Bn
Dec 31, 2023 2.78 Bn